skip to Main Content

ASCO Issues ‘More Structured Guideline’ for Metastatic Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
ASCO released updated recommendations that incorporate new evidence related to second-line therapy for patients with metastatic pancreatic cancer who progressed on or experienced intolerable toxicity during first-line therapy.

The recommendations — issued earlier this year — incorporate research published since the society released its initial guidelines in “With this most recent update, ASCO has offered a much more structured guideline. There is an order of preference for treatment and it is a useful tool for clinicians,” . . . Read more . . .

Back To Top